WELLINGTON MANAGEMENT GROUP LLP - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 132 filers reported holding INTERSECT ENT INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q1 2022$627,000
+2.5%
22,3950.0%0.00%
Q4 2021$612,000
+0.5%
22,3950.0%0.00%
Q3 2021$609,000
-97.9%
22,395
-98.1%
0.00%
-100.0%
Q4 2019$29,016,000
+40.6%
1,165,317
-4.0%
0.01%
+20.0%
Q3 2019$20,638,000
-14.4%
1,213,313
+14.5%
0.01%0.0%
Q2 2019$24,112,000
-53.7%
1,059,376
-34.5%
0.01%
-58.3%
Q1 2019$52,023,000
-38.6%
1,618,147
-46.2%
0.01%
-42.9%
Q4 2018$84,789,000
-3.9%
3,008,862
-2.0%
0.02%
+10.5%
Q3 2018$88,232,000
-20.6%
3,068,972
+3.4%
0.02%
-24.0%
Q2 2018$111,111,000
-9.2%
2,966,913
-4.8%
0.02%
-10.7%
Q1 2018$122,435,000
+19.9%
3,115,380
-1.2%
0.03%
+21.7%
Q4 2017$102,142,000
+5.2%
3,152,558
+1.1%
0.02%
+4.5%
Q3 2017$97,089,000
+34.6%
3,116,835
+20.7%
0.02%
+29.4%
Q2 2017$72,158,000
+44.0%
2,581,661
-11.6%
0.02%
+41.7%
Q1 2017$50,095,000
+42.3%
2,921,012
+0.4%
0.01%
+33.3%
Q4 2016$35,215,000
-43.1%
2,910,329
-25.5%
0.01%
-40.0%
Q3 2016$61,877,000
+21.7%
3,906,379
-0.7%
0.02%
+15.4%
Q2 2016$50,861,000
-20.9%
3,933,597
+16.3%
0.01%
-23.5%
Q1 2016$64,266,000
-18.9%
3,382,391
-4.0%
0.02%
-19.0%
Q4 2015$79,252,000
+108.9%
3,522,321
+117.2%
0.02%
+90.9%
Q3 2015$37,945,000
+33.0%
1,621,579
+62.7%
0.01%
+57.1%
Q2 2015$28,533,000
+44.6%
996,612
+30.5%
0.01%
+40.0%
Q1 2015$19,727,000
+31.2%
763,739
-5.8%
0.01%
+25.0%
Q4 2014$15,036,000
-9.3%
810,571
-24.2%
0.00%
-20.0%
Q3 2014$16,574,0001,069,2480.01%
Other shareholders
INTERSECT ENT INC shareholders Q1 2022
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 186,561$5,364,0004.51%
First Light Asset Management, LLC 517,121$14,867,0002.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,147,950$61,754,0002.21%
HealthCor Management, L.P. 1,950,000$56,063,0001.86%
PURA VIDA INVESTMENTS, LLC 200,000$5,750,0001.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 112,000$2,469,0001.17%
Broadfin Capital, LLC 234,200$6,733,0000.99%
Lombard Odier Asset Management (USA) Corp 240,000$6,900,0000.51%
PURA VIDA INVESTMENTS, LLC 83,527$2,401,0000.50%
Rock Springs Capital Management LP 460,000$13,225,0000.48%
View complete list of INTERSECT ENT INC shareholders